Hogan SL - Search Results

1

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH. Hogan SL, et al. Ann Intern Med. 2005 Nov 1;143(9):621-31. doi: 10.7326/0003-4819-143-9-200511010-00005. Ann Intern Med. 2005. PMID: 16263884

2

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.

Falk RJ, Hogan SL, Muller KE, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Ann Intern Med. 1992 Mar 15;116(6):438-45. doi: 10.7326/0003-4819-116-6-438. Ann Intern Med. 1992. PMID: 1371211 Clinical Trial.

3

Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).

Falk RJ, Hogan SL, Wilkman AS, Terrell RS, Lauritzen S, Charles LA, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Neth J Med. 1990 Apr;36(3-4):121-5. Neth J Med. 1990. PMID: 2162486 No abstract available.

4

Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Falk RJ, Hogan S, Carey TS, Jennette JC. Falk RJ, et al. Ann Intern Med. 1990 Nov 1;113(9):656-63. doi: 10.7326/0003-4819-113-9-656. Ann Intern Med. 1990. PMID: 2221646

5

A review of therapeutic studies of idiopathic membranous glomerulopathy.

Hogan SL, Muller KE, Jennette JC, Falk RJ. Hogan SL, et al. Am J Kidney Dis. 1995 Jun;25(6):862-75. doi: 10.1016/0272-6386(95)90568-5. Am J Kidney Dis. 1995. PMID: 7771482

6

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.

Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Detwiler RK, et al. Among authors: hogan sl. Kidney Int. 1994 May;45(5):1416-24. doi: 10.1038/ki.1994.185. Kidney Int. 1994. PMID: 8072254

7

Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Hogan SL, et al. J Am Soc Nephrol. 1996 Jan;7(1):23-32. doi: 10.1681/ASN.V7123. J Am Soc Nephrol. 1996. PMID: 8808106

8

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Nachman PH, Hogan SL, Jennette JC, Falk RJ. Nachman PH, et al. Among authors: hogan sl. J Am Soc Nephrol. 1996 Jan;7(1):33-9. doi: 10.1681/ASN.V7133. J Am Soc Nephrol. 1996. PMID: 8808107 Clinical Trial.

9

A renal biopsy in essential for the management of ANCA-positive patients with glomerulonephritis.

Falk RJ, Moore DT, Hogan SL, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):230-1. Sarcoidosis Vasc Diffuse Lung Dis. 1996. PMID: 8946588 Review. No abstract available.

10

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network.

Dooley MA, Hogan S, Jennette C, Falk R. Dooley MA, et al. Kidney Int. 1997 Apr;51(4):1188-95. doi: 10.1038/ki.1997.162. Kidney Int. 1997. PMID: 9083285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results